326 related articles for article (PubMed ID: 22142963)
1. Paradigm shift in the pharmacological management of periodontal diseases.
Hasturk H; Kantarci A; Van Dyke TE
Front Oral Biol; 2012; 15():160-76. PubMed ID: 22142963
[TBL] [Abstract][Full Text] [Related]
2. Proresolution mediators and receptors: novel drug targets for enhancing pharmacological armamentarium against periodontal inflammation.
Grover V; Malhotra R; Kapoor A; Singh J; Sachdeva S
Infect Disord Drug Targets; 2013 Feb; 13(1):75-84. PubMed ID: 23713671
[TBL] [Abstract][Full Text] [Related]
3. The management of inflammation in periodontal disease.
Van Dyke TE
J Periodontol; 2008 Aug; 79(8 Suppl):1601-8. PubMed ID: 18673016
[TBL] [Abstract][Full Text] [Related]
4. Resolution of inflammation: a new paradigm for the pathogenesis of periodontal diseases.
Van Dyke TE; Serhan CN
J Dent Res; 2003 Feb; 82(2):82-90. PubMed ID: 12562878
[TBL] [Abstract][Full Text] [Related]
5. Natural resolution of inflammation.
Freire MO; Van Dyke TE
Periodontol 2000; 2013 Oct; 63(1):149-64. PubMed ID: 23931059
[TBL] [Abstract][Full Text] [Related]
6. Host-mediated resolution of inflammation in periodontal diseases.
Kantarci A; Hasturk H; Van Dyke TE
Periodontol 2000; 2006; 40():144-63. PubMed ID: 16398691
[No Abstract] [Full Text] [Related]
7. Lipoxins and new lipid mediators in the resolution of inflammation.
Schwab JM; Serhan CN
Curr Opin Pharmacol; 2006 Aug; 6(4):414-20. PubMed ID: 16750421
[TBL] [Abstract][Full Text] [Related]
8. Atherosclerosis, Periodontal Disease, and Treatment with Resolvins.
Hamilton JA; Hasturk H; Kantarci A; Serhan CN; Van Dyke T
Curr Atheroscler Rep; 2017 Nov; 19(12):57. PubMed ID: 29110146
[TBL] [Abstract][Full Text] [Related]
9. Periodontal host modulation with antiproteinase, anti-inflammatory, and bone-sparing agents. A systematic review.
Reddy MS; Geurs NC; Gunsolley JC
Ann Periodontol; 2003 Dec; 8(1):12-37. PubMed ID: 14971246
[TBL] [Abstract][Full Text] [Related]
10. The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution.
Serhan CN; Chiang N; Dalli J
Semin Immunol; 2015 May; 27(3):200-15. PubMed ID: 25857211
[TBL] [Abstract][Full Text] [Related]
11. Resolvin E1 regulates inflammation at the cellular and tissue level and restores tissue homeostasis in vivo.
Hasturk H; Kantarci A; Goguet-Surmenian E; Blackwood A; Andry C; Serhan CN; Van Dyke TE
J Immunol; 2007 Nov; 179(10):7021-9. PubMed ID: 17982093
[TBL] [Abstract][Full Text] [Related]
12. Anti-inflammatory and proresolving lipid mediators.
Serhan CN; Yacoubian S; Yang R
Annu Rev Pathol; 2008; 3():279-312. PubMed ID: 18233953
[TBL] [Abstract][Full Text] [Related]
13. Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways.
Serhan CN
Annu Rev Immunol; 2007; 25():101-37. PubMed ID: 17090225
[TBL] [Abstract][Full Text] [Related]
14. E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinical trials, and targeted precision nutrition.
Serhan CN; Libreros S; Nshimiyimana R
Semin Immunol; 2022 Jan; 59():101597. PubMed ID: 35227568
[TBL] [Abstract][Full Text] [Related]
15. Safety and Preliminary Efficacy of a Novel Host-Modulatory Therapy for Reducing Gingival Inflammation.
Hasturk H; Schulte F; Martins M; Sherzai H; Floros C; Cugini M; Chiu CJ; Hardt M; Van Dyke T
Front Immunol; 2021; 12():704163. PubMed ID: 34589083
[TBL] [Abstract][Full Text] [Related]
16. Resolvins as proresolving inflammatory mediators in cardiovascular disease.
Capó X; Martorell M; Busquets-Cortés C; Tejada S; Tur JA; Pons A; Sureda A
Eur J Med Chem; 2018 Jun; 153():123-130. PubMed ID: 28732558
[TBL] [Abstract][Full Text] [Related]
17. Lipoxins and resolvins in inflammatory bowel disease.
Weylandt KH; Kang JX; Wiedenmann B; Baumgart DC
Inflamm Bowel Dis; 2007 Jun; 13(6):797-9. PubMed ID: 17262807
[TBL] [Abstract][Full Text] [Related]
18. Pro-resolving mediators in the regulation of periodontal disease.
Van Dyke TE
Mol Aspects Med; 2017 Dec; 58():21-36. PubMed ID: 28483532
[TBL] [Abstract][Full Text] [Related]
19. Novel chemical mediators in the resolution of inflammation: resolvins and protectins.
Serhan CN
Anesthesiol Clin; 2006 Jun; 24(2):341-64. PubMed ID: 16927933
[TBL] [Abstract][Full Text] [Related]
20. [Resolution of inflammation--pharmacological aspects].
Leon MM; Jaba IM; Cozma CD; Albu E; Bahnea R; Mungiu OC
Rev Med Chir Soc Med Nat Iasi; 2011; 115(2):470-6. PubMed ID: 21870743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
